Search clinical trials for: mm3 cubic millimeter(s)

Total 65497 results

Asker & Baerum Hospital

Completed

Effect of Perioperative i.v. Low-dose S(+) Ketamine

Pain | Hemorrhoids

Norway
Hopital of Melun

Completed

Association Between Fear of Falling and Spinal Stiffness. (RAAPC)

Old Age; Atrophy | Fear of Injury | Joint(S) Degeneration

France
Medical University Innsbruck

Completed

Cleansing Efficacy of Waist-shaped Interdental Brushes. (Waist-shaped)

Periodontitis, Adult

Austria
Vivacelle Bio

Active, not recruiting

VBI-S for the Treatment of Hypotension in Hypovolemic Septic Shock Patients

Sepsis | Septic Shock | Hypovolemia

United States
Shaare Zedek Medical Center

Completed

TRAUMEEL S in Reducing Pain After Correction of Hallux Valgus-Clinical Trial

Post Hallux Valgus Repair Pain

Israel
Karaganda Medical University
McMaster University

Completed

Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

Covid19 | Vaccine Adverse Reaction

Kazakhstan
Kelowna Gastroenterology Associates
Veteran Affairs Sepulveda Ambulatory Care Cente

Completed

Investigation of Cecal Intubation Rates and Pain Levels Between Water Exchange and Air Insufflation Flexible Sigmoidoscopy

Colorectal Cancer

United States, Canada
Hallym University Medical Center
Jeil Pharmaceutical Co., Ltd.

Unknown

Docetaxel and S-1 for Advanced Esophageal Cancer

Esophageal Neoplasms

Korea, Republic of
HIV Prevention Trials Network

Completed

HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)

HIV

United States
Aurinia Pharmaceuticals Inc.
United BioSource, LLC

Recruiting

A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US (ENLIGHT-LN)

Lupus Nephritis

United States
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Recruiting

A Pilot Study of the Use of 129Xe and 1H MRI to Measure the Modulation of Eosinophil-Related Inflammation by Mepolizumab In COPD (SUMMER)

COPD

United Kingdom
Tilburg University
Dutch Cancer Society

Completed

Sexual Dysfunction and the Quality of Sexual Life in Patients With Colorectal Cancer and Their Partners.

Colorectal Cancer Patients and Their Partners

Netherlands
Bial - Portela C S.A.

Completed

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Epilepsy

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of Food on BIA 6-512 (Trans-resveratrol)

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability and Steady-state Pharmacokinetics of BIA 6-512

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. (BIPARKII)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Terminated

Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain

Painful Diabetic Neuropathy

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy

Partial Epilepsy

Portugal
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; British Heart Foundation

Completed

Healthy Volunteer Study of Clopidogrel and Rifampicin

Coronary Artery Disease

United Kingdom
ZonMw: The Netherlands Organisation for Health...
Radboud University Medical Center; Sint Maartenskliniek; Reumafonds

Completed

Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk

Fibromyalgia

Netherlands
IRCCS Azienda Ospedaliero-Universitaria di Bologna

Completed

Short Term Physiological Effects of Nasal High Flow Oxygen on Respiratory Mechanics

COPD | Chronic Hypercapnic Respiratory Failure

Italy
Sheffield Teaching Hospitals NHS Foundation Trust

Recruiting

Developing a New EEG Method for the Early Diagnosis of Dementia

Dementia

United Kingdom
RAV Brabant MWN
Jeroen Bosch Ziekenhuis

Enrolling by invitation

A Feasibility Study for Elective Cardioversion of Atrial Fibrillation at Home (Electra-1)

Emergency Medical Services | Electric Countershock

Netherlands
Contamac Ltd

Withdrawn

Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A

Ametropia

Germany
Bial - Portela C S.A.

Completed

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Healthy

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Monotherapy for Patients With Newly Diagnosed Partial-onset Seizures

Epilepsy

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

Parkinson's Disease (PD)

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study to Investigate the Tolerability, Steady-state Pharmacokinetics and Erythrocyte COMT Inhibition of BIA 3-202

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

Parkinson's Disease

Portugal
Bial - Portela C S.A.

Completed

Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

Parkinson Disease

Portugal
Bial - Portela C S.A.

Completed

Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive.

Epilepsy

Portugal
Bial - Portela C S.A.

Completed

Efficacy and Safety Study of BIA 2-093 in Combination With Other Anti-Epileptic Drugs to Treat Partial Epilepsy

Partial Epilepsy

Portugal
Jeroen Bosch Ziekenhuis

Completed

Effect of Dynamic Light Application on Performance of ICU Nurses (Tefflon)

Sustained Selective Attention | Divided Attention

Netherlands
Uppsala University

Completed

Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

Peritoneal Carcinomatosis

Sweden
Merck Sharp & Dohme LLC

Completed

V710 First-In-Man (FIM) Study (V710-001)

Staphylococcal Infections
SolAeroMed Inc.

Not yet recruiting

Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.

Post Acute COVID-19 Syndrome | Long COVID | COVID-19 Respiratory Infection
FHI 360
United States Agency for International Development (USAID)

Completed

A Prospective Observational Study of the Clinical Performance of Femplant in Pakistan

Contraception

Pakistan
Norwegian University of Science and Technology

Completed

Medication-overuse Headache (MOH): Withdrawal or Use of Preventative Medications Directly?

Headache

Norway
DermBiont, Inc.

Terminated

Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo

Atopic Dermatitis

Dominican Republic
M.D. Anderson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Unknown

Epidemiology Controls Using Healthy Participants

Healthy

United States
The George Washington University Biostatistics...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix (PROSPECT)

Short Cervical Length

United States
Sandoz

Completed

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease (GIANT)

Crohn´s Disease

Austria, Germany, Poland, Spain, Sweden
Dr. Falk Pharma GmbH

Completed

9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease

Crohn´s Disease

Germany
University of Erlangen-Nürnberg Medical School

Completed

Endomicroscopy and Crohn´s Disease

Crohn´s Disease

Germany
University of Alberta

Recruiting

Photobiomodulation for Pediatric Hypertrophic Tonsils

Obstructive Sleep Apnea | Pediatric Sleep Apnea | Tonsils Hypertrophy

Canada

Search clinical trials for: mm3 cubic millimeter(s)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations